Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Inclusion Criteria

• •1. Must have recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
• •2. Treating physician has determined that treatment with Tivdak is appropriate for the participant according to US Prescribing Information
• •3. Must sign an informed consent form indicating that the participant understands the purpose and procedures required for the study and are willing to participate
• •4. Must be willing to undergo repeated ocular assessments as required by the study and regular clinic visits according to local standard practice of the study site
• •5. Must agree to use effective contraception according to the US Prescribing Information